Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
OCDX was delisted on the 26th of May, 2022.
170 hedge funds and large institutions have $4.38B invested in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 59 increasing their positions, 50 reducing their positions, and 40 closing their positions.
66% more call options, than puts
Call options by funds: $1.23M | Put options by funds: $737K
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
20% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 40
18% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 50
5% more funds holding
Funds holding: 162 → 170 (+8)
13% less capital invested
Capital invested by funds: $5B → $4.38B (-$629M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$43.7M |
| 2 |
AC
Armistice Capital
New York
|
+$40.1M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$33.5M |
| 4 |
JP Morgan Chase
New York
|
+$28.8M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$23.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$64.6M |
| 2 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$44.7M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$38.3M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$29.4M |
| 5 |
Jennison Associates
New York
|
-$26M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
201
Brown Advisory
Baltimore,
Maryland
| – | -$321K | -14,994 | Closed |
|
202
Ameriprise
Minneapolis,
Minnesota
| – | -$320K | -14,945 | Closed |
|
|
BAM
203
Blueshift Asset Management
Red Bank,
New Jersey
| – | -$286K | -13,355 | Closed |
|
|
AR
204
Advisory Research
Chicago,
Illinois
| – | -$281K | -13,153 | Closed |
|
205
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$90K | -4,202 | Closed |
|
|
SOW
206
State of Wyoming
Cheyenne,
Wyoming
| – | -$55K | -2,577 | Closed |
|
|
WAM
207
Wolverine Asset Management
Chicago,
Illinois
| – | -$21K | -1,000 | Closed |
|
|
QCG
208
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$3K | -128 | Closed |
|
|
HCP
209
Hexagon Capital Partners
Rogers,
Arkansas
| – | +$414 | +23 | New |
|
OCDX Hedge Fund Activity: Q1 2022 in Review
170 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) for Q1 2022, worth a combined $4.38B — down 13% from $5B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new OCDX positions and 40 closed out — a net gain of 8 holders — while 59 added to existing stakes and 50 trimmed.
The largest buyer was Farallon Capital Management, opening a new position worth an estimated $43.7M. The largest seller was Janus Henderson Group, cutting an estimated $64.6M.
- 170 institutional investors held Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) as of Q1 2022, up from 162 in Q4 2021.
- Funds reported $4.38B of Ortho Clinical Diagnostics Holdings plc Ordinary Shares stock for Q1 2022, down 13% quarter-over-quarter.
- 48 funds opened new Ortho Clinical Diagnostics Holdings plc Ordinary Shares positions in Q1 2022 and 40 closed out, a net change of +8 holders.
- The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares buyer in Q1 2022 was Farallon Capital Management, an estimated $43.7M added.
- The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares seller in Q1 2022 was Janus Henderson Group, an estimated $64.6M sold.
Based on aggregated 13F filings for Q1 2022.